UTI GROUP (6WL.F)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. This filer's financial year end could not be read from its revenue history, so quarters are labelled by the calendar. Amounts in EUR.

Revenue Annual

0 8M 16M 24M 2021: 17.9M 2022: 21.3M 2023: 21.2M 2024: 20.8M 2025: 21.6M 2021 2022 2023 2024 2025

Gross Profit Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Annual

-7.5M -5M -2.5M 0 2.5M 5M 7.5M 2021: -155K 2022: 113K 2023: 30K 2024: -6.9M 2025: -712K 2021 2022 2023 2024 2025

Net Income Annual

-7.5M -5M -2.5M 0 2.5M 5M 7.5M 2021: -330K 2022: -114K 2023: -183K 2024: -6.7M 2025: -668K 2021 2022 2023 2024 2025

Cost of Revenue Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Annual

-1.1M -700K -350K 0 350K 700K 1.1M 2021: -934K 2022: 806K 2023: -732K 2024: -531K 2025: -718K 2021 2022 2023 2024 2025

Free Cash Flow Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.